81 related articles for article (PubMed ID: 2791978)
1. Partial characterization of a parathyroid hormone-stimulated resorption factor(s) from osteoblast-like cells.
Perry HM; Skogen W; Chappel J; Kahn AJ; Wilner G; Teitelbaum SL
Endocrinology; 1989 Oct; 125(4):2075-82. PubMed ID: 2791978
[TBL] [Abstract][Full Text] [Related]
2. Constitutive expression of osteoclast-stimulating activity by normal clonal osteoblast-like cells: effects of parathyroid hormone and 1,25-dihydroxyvitamin D3.
Collin P; Guenther HL; Fleisch H
Endocrinology; 1992 Sep; 131(3):1181-7. PubMed ID: 1505460
[TBL] [Abstract][Full Text] [Related]
3. Carboxyl-terminal parathyroid hormone fragments stimulate osteoclast-like cell formation and osteoclastic activity.
Kaji H; Sugimoto T; Kanatani M; Miyauchi A; Kimura T; Sakakibara S; Fukase M; Chihara K
Endocrinology; 1994 Apr; 134(4):1897-904. PubMed ID: 8137758
[TBL] [Abstract][Full Text] [Related]
4. Osteoblast-like cells in the presence of parathyroid hormone release soluble factor that stimulates osteoclastic bone resorption.
McSheehy PM; Chambers TJ
Endocrinology; 1986 Oct; 119(4):1654-9. PubMed ID: 3463505
[TBL] [Abstract][Full Text] [Related]
5. Involvement of dual signal transduction systems in the stimulation of osteoclast-like cell formation by parathyroid hormone and parathyroid hormone-related peptide.
Kaji H; Sugimoto T; Kanatani M; Fukase M; Chihara K
Biochem Biophys Res Commun; 1993 Jul; 194(1):157-62. PubMed ID: 8392835
[TBL] [Abstract][Full Text] [Related]
6. Development of monoclonal antibodies to parathyroid hormone-induced resorptive factors from osteoblast-like cells.
Perry HM; Gurbani S
Calcif Tissue Int; 1992 Mar; 50(3):237-44. PubMed ID: 1617498
[TBL] [Abstract][Full Text] [Related]
7. Interaction between effects of parathyroid hormone and bisphosphonate on regulation of osteoclast activity by the osteoblast-like cell line UMR-106.
Yu X; Schøller J; Foged NT
Bone; 1996 Oct; 19(4):339-45. PubMed ID: 8894139
[TBL] [Abstract][Full Text] [Related]
8. Parathyroid hormone-lymphocyte interactions modulate bone resorption.
Perry HM
Endocrinology; 1986 Nov; 119(5):2333-9. PubMed ID: 3769872
[TBL] [Abstract][Full Text] [Related]
9. Inducible production of nitric oxide in osteoblast-like cells and in fetal mouse bone explants is associated with suppression of osteoclastic bone resorption.
Löwik CW; Nibbering PH; van de Ruit M; Papapoulos SE
J Clin Invest; 1994 Apr; 93(4):1465-72. PubMed ID: 8163651
[TBL] [Abstract][Full Text] [Related]
10. Macrophage colony-stimulating factor release and receptor expression in bone cells.
Weir EC; Horowitz MC; Baron R; Centrella M; Kacinski BM; Insogna KL
J Bone Miner Res; 1993 Dec; 8(12):1507-18. PubMed ID: 8304053
[TBL] [Abstract][Full Text] [Related]
11. Suramin inhibits bone resorption and reduces osteoblast number in a neonatal mouse calvarial bone resorption assay.
Walther MM; Kragel PJ; Trahan E; Venzon D; Blair HC; Schlesinger PH; Jamai-Dow C; Ewing MW; Myers CE; Linehan WM
Endocrinology; 1992 Nov; 131(5):2263-70. PubMed ID: 1425426
[TBL] [Abstract][Full Text] [Related]
12. Osteoblastic cells mediate osteoclastic responsiveness to parathyroid hormone.
McSheehy PM; Chambers TJ
Endocrinology; 1986 Feb; 118(2):824-8. PubMed ID: 3455914
[TBL] [Abstract][Full Text] [Related]
13. Carboxyl-terminal peptides from parathyroid hormone-related protein stimulate osteoclast-like cell formation.
Kaji H; Sugimoto T; Kanatani M; Fukase M; Chihara K
Endocrinology; 1995 Mar; 136(3):842-8. PubMed ID: 7867592
[TBL] [Abstract][Full Text] [Related]
14. Effects of arachidonic acid, docosahexaenoic acid, prostaglandin E(2) and parathyroid hormone on osteoprotegerin and RANKL secretion by MC3T3-E1 osteoblast-like cells.
Coetzee M; Haag M; Kruger MC
J Nutr Biochem; 2007 Jan; 18(1):54-63. PubMed ID: 16650751
[TBL] [Abstract][Full Text] [Related]
15. Estrogen blocks parathyroid hormone (PTH)-stimulated osteoclast-like cell formation by selectively affecting PTH-responsive cyclic adenosine monophosphate pathway.
Kaji H; Sugimoto T; Kanatani M; Nasu M; Chihara K
Endocrinology; 1996 Jun; 137(6):2217-24. PubMed ID: 8641168
[TBL] [Abstract][Full Text] [Related]
16. Osteoclast bone resorption is enhanced in the presence of osteoblasts.
Grano M; Colucci S; Cantatore FP; Teti A; Zambonin Zallone A
Boll Soc Ital Biol Sper; 1990 Nov; 66(11):1051-7. PubMed ID: 2095815
[TBL] [Abstract][Full Text] [Related]
17. The effects of prostaglandin E2, parathyroid hormone, and epidermal growth factor on mitogenesis, signaling, and primary response genes in UMR 106-01 osteoblast-like cells.
Fang MA; Kujubu DA; Hahn TJ
Endocrinology; 1992 Nov; 131(5):2113-9. PubMed ID: 1330491
[TBL] [Abstract][Full Text] [Related]
18. Parathyroid hormone increases the expression of receptors for epidermal growth factor in UMR 106-01 cells.
Drake MT; Baldassare JJ; McConkey CL; Gonzalez EA; Martin KJ
Endocrinology; 1994 Apr; 134(4):1733-7. PubMed ID: 8137737
[TBL] [Abstract][Full Text] [Related]
19. Are osteoblastic cells required for the control of osteoclast activity by parathyroid hormone?
Jilka RL
Bone Miner; 1986 Sep; 1(4):261-6. PubMed ID: 2849485
[TBL] [Abstract][Full Text] [Related]
20. Structural requirements for the action of parathyroid hormone-related protein (PTHrP) on bone resorption by isolated osteoclasts.
Evely RS; Bonomo A; Schneider HG; Moseley JM; Gallagher J; Martin TJ
J Bone Miner Res; 1991 Jan; 6(1):85-93. PubMed ID: 2048435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
